Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

被引:8950
|
作者
Go, AS
Chertow, GM
Fan, DJ
McCulloch, CE
Hsu, CY
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 13期
关键词
D O I
10.1056/NEJMoa041031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.
引用
收藏
页码:1296 / 1305
页数:10
相关论文
共 50 条
  • [1] CARDIOVASCULAR EVENTS AND DEATH IN PEOPLE LIVING WITH CHRONIC KIDNEY DISEASE
    Cuthbertson, L.
    Cash, E.
    Prentice, L.
    Black, A.
    Burgess, J.
    Macintyre, K.
    Saunder, T.
    Kitsos, A.
    Jose, K.
    Raj, R.
    Mckercher, C. E.
    Radford, J.
    Jose, M.
    [J]. NEPHROLOGY, 2020, 25 : 46 - 46
  • [2] Cardiovascular events and death in Japanese patients with chronic kidney disease
    Tanaka, Kenichi
    Watanabe, Tsuyoshi
    Takeuchi, Ayano
    Ohashi, Yasuo
    Nitta, Kosaku
    Akizawa, Tadao
    Matsuo, Seiichi
    Imai, Enyu
    Makino, Hirofumi
    Hishida, Akira
    [J]. KIDNEY INTERNATIONAL, 2017, 91 (01) : 227 - 234
  • [3] Risks of Subsequent Hospitalization and Death in Patients with Kidney Disease
    Daratha, Kenn B.
    Short, Robert A.
    Corbett, Cynthia F.
    Ring, Michael E.
    Alicic, Raclica
    Choka, Randall
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 409 - 416
  • [4] Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
    Borg, Rikke
    Kriegbaum, Margit
    Grand, Mia Klinten
    Lind, Bent
    Andersen, Christen Lykkegaard
    Persson, Frederik
    [J]. BMC PRIMARY CARE, 2023, 24 (01):
  • [5] Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
    Rikke Borg
    Margit Kriegbaum
    Mia Klinten Grand
    Bent Lind
    Christen Lykkegaard Andersen
    Frederik Persson
    [J]. BMC Primary Care, 24
  • [6] Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease
    Li S.
    Foley R.N.
    Collins A.J.
    [J]. International Urology and Nephrology, 2005, 37 (2) : 395 - 402
  • [7] Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease
    Ravani, P.
    Tripepi, G.
    Pecchini, P.
    Mallamaci, F.
    Malberti, F.
    Zoccali, C.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (01) : 95 - 101
  • [8] Death and cardiovascular events after bacteriuria among adult women with chronic kidney disease
    Dhanyamraju, Susmitha
    Foltzer, Michael A.
    Tang, Xiaoqin
    Kirchner, H. Lester
    Perkins, Robert M.
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2012, 5 : 143 - 150
  • [9] CAROTID PLAQUE THICKNESS PREDICTS CARDIOVASCULAR EVENTS AND DEATH IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Bjergfelt, Sasha Saurbrey
    Soerensen, Ida Maria Hjelm
    Kofoed, Klaus F.
    Feldt-Rasmussen, Bo
    Sillesen, Henrik
    Christoffersen, Christina
    Bro, Susanne
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I40 - I41
  • [10] Contemporary Population-based Evaluation of Chronic Kidney Disease With Cardiovascular Events and Death
    Go, Alan S.
    Yang, Jingrong
    Rana, Jamal S.
    Cabrera, Claudia S.
    Stefansson, Bergur
    Greasley, Peter J.
    Tan, Thida C.
    [J]. CIRCULATION, 2017, 136